Stocktoria
Ovid Therapeutics Inc. OVID
Ovid Therapeutics Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| Point72 Asset Management, L.P. | 1,945,727 | $5.2M | 1.49% |
| BlackRock Finance, Inc. | 3,992,346 | $3.1M | 3.07% |
| TWO SIGMA INVESTMENTS, LP | 832,378 | $2.2M | 0.64% |
| RENAISSANCE TECHNOLOGIES LLC | 105,500 | $283,795 | 0.08% |
| CITADEL ADVISORS LLC | 45,700 | $122,933 | 0.04% |
| D. E. Shaw & Co., Inc. | 36,877 | $99,199 | 0.03% |
| MILLENNIUM MANAGEMENT LLC | 32,295 | $86,874 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.